Disease-Modifying Therapies & Symptom Management
WHY IT MATTERS
Understanding your specific ALS subtype—based on where symptoms began and whether you carry genetic mutations like C9orf72 or SOD1—helps your doctor predict disease progression and choose the most appropriate disease-modifying treatments and symptom management strategies for your situation.
ALS progresses differently depending on where symptoms start (in the mouth and throat area versus the arms and legs), whether a person has specific genetic mutations, and how quickly their abilities decline. Doctors measure this decline using a standardized test called the ALSFRS-R to understand each patient's disease pattern and help guide treatment decisions.
Disease progression in ALS varies based on the site of onset (bulbar vs. limb), the presence of genetic mutations (e.g., C9orf72, SOD1), and the rate of functional decline, as measured by the ALS Functional Rating Scale–Revised (ALSFRS-R). The post Disease-Modifying Therapies & Symptom Management appeared first on ALS News Today .
ASK YOUR DOCTOR
Ask your neurologist whether your ALS is bulbar-onset or limb-onset, if genetic testing has been done, and what your current ALSFRS-R score is—this information helps personalize your treatment plan.